Chimeric antigen receptors and uses thereof
US-2026034195-A1 · Feb 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Dranoff Glenn patents
Dranoff Glenn is listed as an inventor on 87 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dranoff Glenn |
| Total patents | 87 |
| First publication | Feb 18, 2016 |
| Latest publication | Feb 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Chimeric antigen receptors and uses thereof
US-12383601-B2 · Aug 12, 2025 · US
Anti-cd19 agent and b cell targeting agent combination therapy for treating b cell malignancies
US-2025215081-A1 · Jul 3, 2025 · US
Combination therapies comprising antibody molecules to tim-3
US-2025213684-A1 · Jul 3, 2025 · US
Nkg2d-fc for immunotherapy
US-2025092114-A1 · Mar 20, 2025 · US
Compositions and methods for immunooncology
US-2024417722-A1 · Dec 19, 2024 · US
Antibody molecules to pg-l1 and methods of treating cancer and infectious diseases
US-2024343808-A1 · Oct 17, 2024 · US
Dosing regimen and pharmaceutical combination comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives
US-2024245670-A1 · Jul 25, 2024 · US
Compositions and methods for immunooncology
US-12037583-B2 · Jul 16, 2024 · US
Nkg2d-ig fusion protein for cancer immunotherapy
US-2024190942-A1 · Jun 13, 2024 · US
Recent patents
Latest publications not already listed above.
Combination vaccine devices and methods of killing cancer cells
US-11998593-B2 · Jun 4, 2024 · US
Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore
US-2024139244-A1 · May 2, 2024 · US
NKG2D-IG fusion protein for cancer immunotherapy
US-11851472-B2 · Dec 26, 2023 · US
Methods and Compositions for Reducing Immunosupression by Tumor Cells
US-2023383298-A1 · Nov 30, 2023 · US
Compositions and methods for in vivo generation of car expressing cells
US-2023302155-A1 · Sep 28, 2023 · US
Methods of making chimeric antigen receptor-expressing cells
US-2023256017-A1 · Aug 17, 2023 · US
Methods of making chimeric antigen receptor-expressing cells
US-2023174933-A1 · Jun 8, 2023 · US
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
US-11624093-B2 · Apr 11, 2023 · US
Methods and compositions for reducing immunosuppression by tumor cells
US-11597934-B2 · Mar 7, 2023 · US
Antibody molecules to cd73 and uses thereof
US-2023039109-A1 · Feb 9, 2023 · US
Combination therapies comprising antibody molecules to pd-1
US-2023013364-A1 · Jan 19, 2023 · US
Methods of making chimeric antigen receptor-expressing cells
US-2022364055-A1 · Nov 17, 2022 · US
Immunomodulation by IAP Inhibitors
US-2022296581-A1 · Sep 22, 2022 · US
Immunomodulation by IAP inhibitors
US-11382905-B2 · Jul 12, 2022 · US
Combination therapies comprising antibody molecules to lag-3
US-2022153835-A1 · May 19, 2022 · US
Combination therapies comprising antibody molecules to tim-3
US-2022133889-A1 · May 5, 2022 · US
Nkg2d-fc for immunotherapy
US-2022002382-A1 · Jan 6, 2022 · US
Antibody molecules to pd-l1 and uses thereof
US-2021284737-A1 · Sep 16, 2021 · US
Chimeric antigen receptors and uses thereof
US-2021220404-A1 · Jul 22, 2021 · US
Antibody molecules to cd73 and uses thereof
US-2021214459-A1 · Jul 15, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Dana Farber Cancer Inst Inc | 61 |
| Novartis Ag | 42 |
| Harvard College | 22 |
| Dranoff Glenn | 8 |
| Intellia Therapeutics Inc | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 80 |
| A61K45/06 | 54 |
| C07K2317/76 | 37 |
| A61P37/04 | 36 |
| A61K2039/505 | 33 |